National Jewish Health — Denver, Colorado

Public research footprint of National Jewish Health, compiled from the ClinicalTrials.gov public registry.

482

Registered studies

151

Active

Recruiting now

256

Completed

Stopped or withdrawn

Most-studied conditions

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Ovarian Carcinoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma

Recently updated registry entries

NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03984448 — Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Jewish Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.